KRAB
14 Dec 2020
Trial Summary
Kidney Cancer Australian registry and Biobank
Acronym:
KRAB
ACTRN/NCT /ethics:
–
Scientific title:
Kidney Cancer Australian Registry and Biobank
Sponsor / Cooperative group:
Melbourne Health
Trial & Patient Characteristics
| Cancer Type | Kidney |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | All phases |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | - |
| Cancer Stage | All stages |
| Anticipated Start Date | - |
| Anticipated End Date | - |
Participating Hospitals
| Hospital | Icon Cancer Centre Adelaide |
|---|---|
| Clinical Trial Coordinator | Sue Yeend |
| sue.yeend@icon.team | |
| Phone | 08 8292 2204 |
| Principal Investigator | Dr Francis Parnis |
| Recruitment Status | Recruiting |